Innovation Will Be Rewarded in Pharma, Says Jain

The transcript discusses the complexities of decision-making in the healthcare sector amidst regulatory uncertainties. It highlights the unique aspects of the pharmaceutical industry, where innovation is key to success, and profitability is linked to leadership in specific categories rather than scale. The discussion includes strategies for growth, emphasizing the importance of focused innovation and the debate between organic growth and acquisitions. Eli Lilly's approach to innovation through homegrown efforts is also mentioned, contrasting with other companies that may seek external acquisitions to boost growth.

What are the five therapeutic areas that the speaker mentions focusing on?

What does the speaker suggest about the approach to acquisitions in the pharmaceutical industry?